Singapore Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Singapore Clinical Nutrition for Diabetes Care Market Analysis

$ 3999

The Singapore Clinical Nutrition for Diabetes Care Market was valued at $2.58 Mn in 2023 and is predicted to grow at a CAGR of 5.38% from 2023 to 2030, to $3.72 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Nutribio, Pfizer Inc., and Novo Nordisk among others.

ID: IN10SGPH566 CATEGORY: Pharmaceuticals GEOGRAPHY: Singapore AUTHOR: Avantika Gupta

Buy Now

Singapore Clinical Nutrition for Diabetes Care Market Executive Summary

The Singapore Clinical Nutrition for Diabetes Care Market is at around $2.58 Mn in 2023 and is projected to reach $3.72 Mn in 2030, exhibiting a CAGR of 5.38% during the forecast period.

Clinical nutrition for diabetes care refers to specialized dietary interventions and nutritional strategies designed to manage and improve the health outcomes of people with diabetes mellitus. It involves using evidence-based nutrition treatment to help diabetic patients maintain blood sugar control, avoid complications, and enhance their overall metabolic health. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and enhance overall health outcomes for those with diabetes.

The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is one of the factors contributing to the growth of the global clinical nutrition market. Obesity is a major factor leading to diabetes. Clinical nutrition including medical foods and parenteral nutrition can help relieve symptoms or slow down the progression of a chronic condition. As the number of people with diabetes continues to grow, so does the demand for these specialized food products. Patients afflicted with diabetes are at higher risk of comorbidities, as diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation, as reported by the WHO.

The leading pharmaceutical companies include Abbott Nutrition, Sanofi is known for its extensive portfolio of medications, including those essential for diabetes care. Nestlé Health Science, Pfizer Inc., and Nutribio are also significant contributors to the Clinical Nutrition for Diabetes Care landscape, with continuous research and development activities.

Singapore Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Increasing Prevalence of Diabetes: Singapore has one of the highest rates of diabetes in the developed world. As per the International Diabetes Federation, about 14.9% of adults in Singapore have diabetes. This growing burden of diabetes is a major driver for the clinical nutrition market in Singapore and there is an increasing acknowledgment of the value of nutrition therapy in diabetes treatment and the significance of clinical nutrition products and services in improving patient outcomes.

Increasing Awareness and Adoption of Clinical Nutrition: There has been a growing awareness among healthcare professionals and the general public in Singapore about the importance of clinical nutrition in managing diabetes. This increased awareness, coupled with the availability of evidence-based guidelines and recommendations, has contributed to the adoption of clinical nutrition services in the country.

Increasing Healthcare Expenditure: Singapore's government has been investing heavily in healthcare infrastructure and services to cater to the growing needs of its population. Healthcare spending, comprising both public and private healthcare expenditure, is expected to account for 5.9% of GDP and could go up to 9.0%, providing a favorable environment for the growth of clinical nutrition services.

Initiatives for diabetes management: BE SMART Programme by Diabetes Singapore provides personalized support and education to individuals at risk of developing diabetes or with newly diagnosed Type 2 diabetes. They also aim to educate the public, especially in schools and community events, on adopting healthy lifestyles to prevent type 2 diabetes. They publish and distribute brochures and pamphlets on diabetes prevention.

Market Restraints

High Cost of Specialized Products: Diabetes-specific clinical nutrition solutions are more expensive than regular nutritional supplements and conventional foods. The high cost of these products can limit access for patients, especially those from low-income households and areas with inadequate medical resources. This highlights the economic burden associated with the high cost of specialized therapeutic nutrition products in diabetes care.

Lack of Access to Registered Dietitians: Due to the limited availability of registered dietitians in Singapore, especially in rural or underserved communities, diabetic individuals who require personalized nutrition assessments, counseling, and education may face challenges in accessing these services, potentially hindering the growth of the clinical nutrition market for diabetes care.

Focus on medication and lifestyle changes: Current treatment approaches for diabetes often prioritize medication and lifestyle modifications like diet and exercise. Integrating clinical nutrition into standard care plans may require a shift in focus for some healthcare professionals. Overcoming resistance to adopting specialized clinical nutrition products as part of their dietary management may require extensive patient education and support, potentially slowing down market adoption.

Regulatory Landscape and Reimbursement Scenario

Health Sciences Authority (HSA) is the primary regulatory body responsible for ensuring the safety, quality, and efficacy of all health products in Singapore, including clinical nutrition products. Sale of Food Act regulates the import, manufacture, sale, and advertising of food products, including those intended for special dietary uses like clinical nutrition products.

The Ministry of Health (MOH) in Singapore has implemented various reimbursement policies to support the use of clinical nutrition products for diabetes care. For example, the Chronic Disease Management Programme (CDMP) allows patients to use their MediSave funds to pay for outpatient treatments, including medical nutrition therapy for diabetes. The Singapore government provides financial assistance through schemes like MediFund, which can be used to subsidize the cost of clinical nutrition products and services for patients with financial difficulties.

Competitive Landscape

Key Players

Here are some of the major key players in the Singapore Clinical Nutrition for Diabetes Care Market:

Abbott Nutrition
Pfizer Inc.
Amgen
Nestlé Health Science
Nutribio
GlaxoSmithKline
Sanofi
Agir A Dom
Danone Nutricia
Novo Nordisk

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Singapore Clinical Nutrition for Diabetes Care Market Segmentation

By Product

Oral Nutrition
Parenteral Nutrition
Enteral Feedback Formulas

By Stage

Adult
Paediatric

By Distribution Channel

Online
Retail
Institutional Sales

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.